ENZO BIOCHEM INC - COM (ENZ)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
12.6M
Holdings value Q3 2024
$14.2M
Value change Q3 2024
+$298K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
43
Number of buys Q3 2024
13
Number of sells Q3 2024
-6
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 12.6M $14.2M +$298K $1.12 43
2024 Q2 12.4M $13.5M -$1.82M $1.09 39
2024 Q1 13.8M $17.6M -$1.38M $1.27 39
2023 Q4 16.4M $22.7M -$253K $1.39 44
2023 Q3 16.5M $23.1M -$4.05M $1.40 38
2023 Q2 18.8M $34.7M -$1.84M $1.84 47
2023 Q1 19.8M $48.1M +$2.65M $2.43 52
2022 Q4 18.8M $26.8M -$573K $1.43 48
2022 Q3 20.5M $45.6M -$1.36M $2.23 41
2022 Q2 20.8M $43.1M -$1.09M $2.07 45
2022 Q1 21.4M $62M -$399K $2.90 44
2021 Q4 21.5M $69M -$9.63M $3.21 53
2021 Q3 23.4M $82.9M -$2.42M $3.54 58
2021 Q2 24.2M $76.6M -$10.9M $3.17 64
2021 Q1 27.5M $94.6M -$5.95M $3.44 76
2020 Q4 29.3M $73.9M +$1.03M $2.52 76
2020 Q3 28.9M $61.1M +$552K $2.11 77
2020 Q2 28.6M $64M -$606K $2.24 76
2020 Q1 28.9M $73M -$8.68M $2.53 69
2019 Q4 32.2M $84.8M -$1.57M $2.63 73
2019 Q3 32.6M $117M +$941K $3.60 82
2019 Q2 32.5M $109M +$2.82M $3.37 90
2019 Q1 32.2M $87.8M +$896K $2.73 74
2018 Q4 31.8M $88.3M -$4.74M $2.78 80
2018 Q3 31.5M $130M -$2.85M $4.12 93
2018 Q2 31.9M $166M +$2.32M $5.19 89
2018 Q1 31.5M $172M +$6.34K $5.48 101
2017 Q4 30.9M $252M +$7.26M $8.15 113
2017 Q3 29.8M $312M +$7.32M $10.47 113
2017 Q2 29.1M $321M +$11.8M $11.04 117
2017 Q1 28.3M $237M +$36M $8.37 108
2016 Q4 26.9M $187M +$1.91M $6.94 105
2016 Q3 23.7M $121M -$2.79M $5.09 108
2016 Q2 24.3M $145M +$14.3M $5.97 101
2016 Q1 22.1M $101M +$817K $4.55 91
2015 Q4 21.9M $98.6M +$6.21M $4.50 81
2015 Q3 21.1M $66.8M +$273K $3.17 76
2015 Q2 21.1M $63.9M -$2.16M $3.03 82
2015 Q1 21.9M $64.5M +$717K $2.95 82
2014 Q4 21.4M $94.9M +$5.77M $4.44 84
2014 Q3 19.6M $101M +$12.8M $5.15 90
2014 Q2 17.1M $89.9M +$21.3M $5.25 83
2014 Q1 13.3M $55.2M +$8.81M $4.16 60